Exchange: NASDAQ·Updated 07:30 PM EDT
ALEC logo

ALEC Alector Inc

$2.46
$0.05
(1.99%)
Today
Closed $2.46
$0.01
(0.41%)
After Hours
Reported EarningsAug 6
Mkt Cap$274.68M
Vol496,601.00

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
55

Bullish Sentiment

How do you feel about ALEC?

Advertisement|Remove ads.